ISSN: 0165-6147

Journal Home

Journal Guideline

Trends in Pharmacological Sciences Q1 Unclaimed

Elsevier Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Trends in Pharmacological Sciences is a journal indexed in SJR in Pharmacology and Toxicology with an H index of 218. It has an SJR impact factor of 3,878 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,878.

Trends in Pharmacological Sciences focuses its scope in these topics and keywords: receptor, gpr, implications, cancer, py, deacetylases, egfr, hyperpolarizing, dpyd, diseasesregulation, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmacology (Q1) Toxicology (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

3,878

SJR Impact factor

218

H Index

101

Total Docs (Last Year)

288

Total Docs (3 years)

6920

Total Refs

3178

Total Cites (3 years)

276

Citable Docs (3 years)

9,93

Cites/Doc (2 years)

68,51

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Reviews Drug Discovery Q1
Pharmacological Reviews Q1
Journal for ImmunoTherapy of Cancer Q1
Annual Review of Pharmacology and Toxicology Q1
Perspectives in Medicinal Chemistry Q1

Compare this journals

Aims and Scope

Best articles by citations

Mice cured of Alzheimer's disease

Phosphodiesterases: the journey towards therapeutics

Anderson and Coyle reply

QSAR: Hansch analysis and related approaches

The lock-and-key principle

Receptor molecular biology. methods in neurosciences vol. 25

PCR in Neuroscience Edited by G. Sarkar, Academic Press, 1995. ¬£42.00 (xv + 455 pages) ISBN 0 12 619255 3

Receptor state and ligand efficacy

Schizophrenia, the dopamine hypothesis and a2-adrenoceptor antagonists

G-protein-coupled receptor dimers in the lime light

Adenosine, antioxidant enzymes and cytoprotection

SHOW MORE ARTICLES

The 'septide-sensitive' tachykinin receptor: still an enigma

A magic life of chemistry

Pharmacodynamics and drug development

Nematode genome sequence dramatically extends the nuclear receptor superfamily

Risks in combination therapy of antidepressant drugs

Detection of receptor subtypes in radioligand binding studies Do saturation and homologous competition studies have different discriminatory power?

Butler et al. reply

NMDA receptor redox sites: are they targets for selective neuronal protection?

CCK receptor polymorphisms: an illustration of emerging themes in pharmacogenomics

A pharmacological link between epilepsy and anxiety?

Searching for magic bullets

The metabotropic glutamate receptors